Claudia Furtado

Cláudia Furtado is a Visiting Assistant Professor at the National School of Public Health (ENSP NOVA) and serves as Director of the Strategic Planning and Information Department at INFARMED - the National Authority for Medicines and Health Products (IP). She represents INFARMED in European networks such as the HTA Coordination Group, WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, and the International Horizon Scanning Initiative. Additionally, she contributes to the advisory board of the DARWIN EU project and the Steering Board of the RWE4Decisions consortium.

• PhD in Public Health from ENSP NOVA
• Master in Public Health from ENSP NOVA
• Degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon

Her research focuses on pharmaceutical systems, encompassing drug policy development, health technology assessment (HTA) frameworks, and pharmaceutical financing mechanisms. She investigates equity in healthcare delivery and financing, particularly regarding access to medicines, and analyzes real-world evidence for decision-making in health systems through projects like RWE4Decisions and DARWIN EU.

Cláudia Furtado actively participates in European collaborations and policy development, with expertise in pharmaceutical pricing, reimbursement strategies, and monitoring drug utilization patterns.